Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-04-30FDA Approved: OTULFI — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for OTULFI (ustekinumab-aauz) from Fresenius Kabi USA, LLC.
-
FDA approval · 2025-04-30FDA Approved: STEQEYMA — Original Application (CELLTRION USA, Inc.)
The FDA approved STEQEYMA (ustekinumab-stba) from Celltrion USA, Inc. under an Original Biologics License Application.
-
FDA approval · 2025-04-30FDA Approved: YESINTEK — Original Application (Biocon Biologics Inc.)
The FDA approved Yesintek (ustekinumab) from Biocon Biologics Inc. under an original Biologics License Application. It is indicated for plaq…
-
FDA approval · 2025-04-30FDA Approved: OTULFI — Original Application (Fresenius Kabi USA, LLC)
OTULFI (USTEKINUMAB-AAUZ) received FDA approval under an Original Application from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis [NA]
The clinical trial is recruiting to evaluate whether the QuantiFERON-CMV diagnostic test can predict cytomegalovirus reactivation in patient…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-04-28FDA Approved: STEQEYMA — Supplemental Application (CELLTRION USA, Inc.)
The FDA approved a supplemental application for STEQEYMA (ustekinumab-stba) from Celltrion USA, Inc.
-
CLINICAL_TRIALS trial_result · 2025-04-28Clinical Trial Update: A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice
A completed clinical trial evaluating symptom improvement after an induction dose of ustekinumab for ulcerative colitis in Japanese practice…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating ABX464 as maintenance therapy for moderate-to-severe ulcerative colitis has completed and posted results, including…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
Real-world study evaluating the effectiveness of ustekinumab in patients with inflammatory bowel disease (Crohn's disease or ulcerative coli…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
A completed clinical trial in Korea sponsored by Janssen Korea studied the clinical course of newly diagnosed moderate-to-severe ulcerative …
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis [EARLY_Phase 1]
An early Phase 1 trial is evaluating exosomes derived from human umbilical cord mesenchymal stem cells (hucMSCs) for active Ulcerative Colit…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms [NA]
A pilot clinical trial evaluating whether changes in sleep timing influence symptoms in inflammatory bowel disease, including ulcerative col…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.
Real-world data were collected on tofacitinib induction therapy for Ulcerative Colitis to assess changes in clinical outcomes and patient-re…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Oral Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial evaluating oral fecal microbiota transplantation for pediatric ulcerative colitis in remission, with the study not …
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Feasibility Pilot Sequential Multiple Assignment Randomized Trial (SMART) for Acute Severe Ulcerative Colitis [Phase 4]
A Phase 4 feasibility pilot SMART trial for acute severe ulcerative colitis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis
Clinical trial update on SIMBA Capsule evaluating small intestinal dysbiosis, with recruitment ongoing for several gastrointestinal and meta…
-
FDA approval · 2025-04-14FDA Approved: OTULFI — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental Biologics License Application for OTULFI (ustekinumab-AAUZ) from Fresenius Kabi USA, LLC.
-
FDA approval · 2025-04-14FDA Approved: MESALAMINE — Original Application (Rising Pharma Holdings, Inc.)
FDA approves the original Abbreviated New Drug Application for Mesalamine from Rising Pharma Holdings, Inc., establishing a generic version …
-
CLINICAL_TRIALS other · 2025-04-13Clinical Trial Update: A Comparative Evaluation of Different Histopathological Indices of Mucosal Healing in Ulcerative Colitis
A clinical trial evaluating different histopathological indices of mucosal healing in ulcerative colitis is listed as not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified Analysis
This completed trial update presents age-stratified results of upadacitinib for refractory inflammatory bowel disease in Asian children and …
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Pro-active Fecal Calprotectin Monitoring PROMOTE-UC
The PROMOTE-UC clinical trial evaluating proactive fecal calprotectin monitoring for ulcerative colitis is currently active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Metformin in Patients With Ulcerative Colitis Treated With Mesalamine [Phase 2]
Phase 2 trial update evaluating metformin in patients with ulcerative colitis who are treated with mesalamine has completed.
-
FDA approval · 2025-04-07FDA Approved: ADALIMUMAB — Supplemental Application (CELLTRION USA, Inc.)
FDA approved a supplemental application for ADALIMUMAB-AATY, a biosimilar adalimumab from Celltrion USA, Inc., in connection with its regula…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis [Phase 2]
A Phase 2 trial investigating repurposed fenofibrate to modulate mTOR/NLRP3 inflammasome in ulcerative colitis has completed.
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Personalized B-fructan Diet in Inflammatory Bowel Disease Patients [NA]
A clinical trial evaluating a personalized B-fructan diet in patients with inflammatory bowel diseases, including ulcerative colitis, is cur…